Evidence map›Paper›PMID 37268010›Full record

Trial reportEndoscopy2023

A prospective multicenter study to evaluate the impact of cryotherapy on dysphagia and quality of life in patients with inoperable esophageal cancer.

Toufic Kachaamy, Neil Sharma, Tilak Shah, Sonmoon Mohapatra, Kimberly Pollard, Christina Zelt, Elaine Jewett, Rigoberto Garcia, Rachel Munsey, Saurabh Gupta and 5 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyClinical Trial
In one paragraph

Trial report in Endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07222657 (Phase 2 Randomized Trial Of Liquid Nitrogen Spray Cryotherapy Prior To Neoadjuvant Systemic Therapy In Locally Advanced Esophageal Adenocarcinoma), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07222657 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Phase 2 Randomized Trial Of Liquid Nitrogen Spray Cryotherapy Prior To Neoadjuvant Systemic Therapy In Locally Advanced Esophageal Adenocarcinoma

TypeinterventionalSponsorCase Comprehensive Cancer CenterRan2026 to 2027Enrolled40ConditionsEsophageal Adenocarcinoma, Esophageal CancerArmsStandard of care chemotherapy, LNSC
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Gastro-Esophageal Disorders of the Geriatric Population.The American journal of gastroenterology · 2025
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Toufic KachaamyDepartment of Gastroenterology, City of Hope Phoenix, Goodyear, Arizona, United States.
Neil SharmaDivision of Interventional Oncology and Surgical Endoscopy, Parkview Cancer Institute, Fort Wayne, Indiana, United States.
Tilak ShahEllen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic, Weston, Florida, United States.
Sonmoon MohapatraDepartment of Gastroenterology and Nutrition, City of Hope Chicago, Zion, Illinois, United States.
Kimberly PollardDivision of Gastroenterology and Hepatology, Central Virginia VA Healthcare System, Richmond, Virginia, United States.
Christina ZeltDivision of Interventional Oncology and Surgical Endoscopy, Parkview Cancer Institute, Fort Wayne, Indiana, United States.
Elaine JewettDepartment of Gastroenterology, City of Hope Phoenix, Goodyear, Arizona, United States.
Rigoberto GarciaDepartment of Gastroenterology, City of Hope Phoenix, Goodyear, Arizona, United States.
Rachel MunseyDivision of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, United States.
Saurabh GuptaDivision of Interventional Oncology and Surgical Endoscopy, Parkview Cancer Institute, Fort Wayne, Indiana, United States.
Mariajose Rojas-DeLeonDivision of Interventional Oncology and Surgical Endoscopy, Parkview Cancer Institute, Fort Wayne, Indiana, United States.
Digant GuptaDivision of Gastroenterology and Hepatology, Central Virginia VA Healthcare System, Richmond, Virginia, United States.
Vivek KaulDivision of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, New York, United States.
Rahul PannalaDepartment of Gastroenterology and Nutrition, City of Hope Chicago, Zion, Illinois, United States.
Pankaj VashiDivision of Gastroenterology and Hepatology, Central Virginia VA Healthcare System, Richmond, Virginia, United States.
Parkview Health · USCity Of Hope National Medical Center · USVA Central California Health Care System · USCity of Hope · USWinnMed · USUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDysphagia palliation in inoperable esophageal cancer continues to be a challenge. Self-expandable metal stents have been the mainstay of endoscopic palliation but have a significant risk of adverse events (AEs). Liquid nitrogen spray cryotherapy is an established modality that can be used with systemic therapy. This study reports the outcomes of cryotherapy, including dysphagia and quality of life (QoL), in patients receiving systemic therapy.

methodsThis was a prospective multicenter cohort study of adults with inoperable esophageal cancer who underwent cryotherapy. QoL and dysphagia scores before and after cryotherapy were compared.

results55 patients received 175 cryotherapy procedures. After a mean of 3.2 cryotherapy sessions, mean QoL improved from 34.9 at baseline to 29.0 at last follow-up (

conclusionIn patients with inoperable esophageal cancer receiving concurrent systemic therapy, adding liquid nitrogen spray cryotherapy was safe and associated with improvement in dysphagia and QoL without causing reflux. More intensive treatment showed a greater improvement in dysphagia and should be considered as the preferred approach.

Indexed as

Deglutition DisordersEsophageal NeoplasmsAdultCohort StudiesCryotherapyHumansNitrogenPalliative CareProspective StudiesQuality of LifeStentsNitrogen

Identifiers

PMID37268010
PMCPMC10533213
OpenAlexW4379184253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.